Dr. Jeffrey Bauer has been named president of ChemWerth, Inc. Dr. Bauer is responsible for leading the day-to-day business operations of the company, as well as planning its future growth strategy.

Dr. Bauer has 18 years of experience in the pharmaceutical and medical device industries. Prior to joining ChemWerth, he was vice president of business development and licensing at Sandoz, a position he held since 2005. At Sandoz, Dr. Bauer was responsible for management of the U.S. generic product portfolio and API sourcing and procurement. Prior to Sandoz, he was employed by Eon Labs, Inc., serving as vice president of business development and licensing. He also held positions at Ivax, AAIPharma and Bio-Rad Laboratories.

“Jeff Bauer is an outstanding talent who is widely recognized throughout the generic pharmaceutical industry as a results-driven thought-leader and visionary. I am highly confident that Jeff will take our business to the next level,” said ChemWerth founder and chief executive officer Peter Werth.

“I am extremely excited by the opportunity to lead ChemWerth, a company that pioneered API sourcing in China,” said Dr. Bauer. “Given ChemWerth’s strong brand and its experienced staff, I intend to expand our reach in bringing unique and creative pharmaceutical business solutions to our customers worldwide.”